PSTV vs PULM

PLUS THERAPEUTICS, Inc. vs Pulmatrix, Inc. — Valuation Comparison 2026

PSTV

Biotechnology
PLUS THERAPEUTICS, Inc.
Quality
4.8
out of 10
Value Trap
36
LOW
Price
$6.43
Last close
Models
9/13
Active
VS

PULM

Biotechnology
Pulmatrix, Inc.
Quality
5.6
out of 10
Value Trap
24
SAFE
Price
$1.38
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType PSTV Fair ValuePSTV Upside PULM Fair ValuePULM Upside
Bayesian DCF Intrinsic $2.02 -68.6% $0.87 -37.1%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $2.09 -67.5% $3.25 +135.2%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for PSTV vs PULM — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

PSTV vs PULM — Which Stock Is More Undervalued?

PULM scores higher with a 5.6/10 quality rating vs PSTV's 4.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing PLUS THERAPEUTICS, Inc. (PSTV) and Pulmatrix, Inc. (PULM) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

PSTV currently trades at $6.43 with a QOC of 4.8/10, while PULM trades at $1.38 with a QOC of 5.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).